ANI Pharmaceuticals, Inc.
ANIP
$67.36
$0.110.16%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | 1.16M | 9.94M | 6.25M | 1.44M | -4.24M |
| Total Depreciation and Amortization | 15.19M | 15.21M | 14.69M | 14.70M | 15.57M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 593.00K | 1.46M | 6.42M | 7.06M | 5.03M |
| Change in Net Operating Assets | 27.80M | 5.57M | -6.73M | -1.77M | -20.76M |
| Cash from Operations | 44.74M | 32.17M | 20.63M | 21.42M | -4.40M |
| Capital Expenditure | -2.28M | -1.74M | -2.50M | -2.35M | -3.14M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | 0.00 |
| Cash Acquisitions | -- | -- | -- | -- | 0.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -2.50M | -2.81M | -4.33M | -4.00K | -4.00K |
| Cash from Investing | -4.78M | -4.55M | -6.83M | -2.35M | -3.14M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -750.00K | -750.00K | -750.00K | -750.00K | -750.00K |
| Issuance of Common Stock | 1.97M | 5.58M | 81.84M | 157.00K | 768.00K |
| Repurchase of Common Stock | -231.00K | -670.00K | -537.00K | -3.55M | -119.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -406.00K | -406.00K | -407.00K | -406.00K | -407.00K |
| Other Financing Activities | -12.50M | -- | -- | -- | -- |
| Cash from Financing | -11.92M | 3.76M | 80.15M | -4.55M | -508.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 28.04M | 31.37M | 93.95M | 14.52M | -8.05M |
